GAD autoantibody affinity in schoolchildren from the general population

Area of Science:

• Immunology
• Endocrinology
• Pediatrics

Background:

• Type 1 diabetes is an autoimmune disease characterized by the destruction of pancreatic beta cells.
• GAD autoantibodies (GADA) are common early markers of type 1 diabetes autoimmunity.
• Stratifying risk in GADA-positive individuals is crucial for timely intervention.

Purpose of the Study:

• To investigate whether GADA affinity is a useful marker for stratifying type 1 diabetes risk in GADA-positive schoolchildren from the general population.
• To determine if high-affinity GADA are associated with progression to type 1 diabetes.

Main Methods:

• Measured GADA affinity using competitive binding experiments in sera from 97 GADA-positive schoolchildren.
• Determined GADA epitope specificity using radiobinding assays with GAD65/GAD67 chimeric proteins.
• Followed children for progression to type 1 diabetes and development of additional autoantibodies.

Main Results:

• GADA affinity varied significantly in single GADA-positive children compared to multiple islet autoantibody-positive children.
• High-affinity GADA (≥ 10(10) l/mol) were associated with HLA-DRB1*03 and specific GAD65 epitopes.
• Twenty-three of 26 children who progressed to type 1 diabetes had high-affinity GADA before disease onset.

Conclusions:

• GADA responses in schoolchildren are heterogeneous.
• High GADA affinity is a significant predictor of type 1 diabetes progression in GADA-positive children from the general population.
• GADA affinity measurement can aid in identifying high-risk individuals for type 1 diabetes.